What is not clear is how much of the revenue received relates to the USA deal they announced last year. The announcement in March 2017 indicated they had a sale for $USD180,000 circa AUD 230,000 There was no detail in the half year report to indicate that there is an issue with recoverability. Maybe they received some of this in Q4 CY17 and Q1 CY 2018 as it shows they received part of this in Q1 CY2017 If this is the case then the subscriptions are still very low. Customer contract value is circa $710,000 as per April Sales announcement which assuming 24 month contracts as the norm gives a monthly revenue of just shy of $30,000. The question is what is management doing to accelerate revenue growth.
- Forums
- ASX - By Stock
- Ann: March 2018 Quarterly Report & Appendix 4C
What is not clear is how much of the revenue received relates to...
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.474M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 23495490 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 222518 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 187500 | 0.008 |
4 | 660631 | 0.007 |
2 | 1091666 | 0.006 |
2 | 1266959 | 0.005 |
1 | 150000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 47144 | 1 |
0.010 | 1000000 | 1 |
0.012 | 305828 | 1 |
0.013 | 159960 | 1 |
0.014 | 71499 | 1 |
Last trade - 16.12pm 25/11/2024 (20 minute delay) ? |
Featured News
CT1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online